Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2009

01-10-2009 | Poster presentation

''Might be something, might not'' - what happens when indeterminate grade screening mamograms are arbitrated?

Authors: J Prynn, N Barr, C Boggis, E Hurley, M Wilson

Published in: Breast Cancer Research | Special Issue 2/2009

Login to get access

Excerpt

Arbitration of screening mammograms following independent double reading with or without consensus has been shown to reduce recall rates and maintain cancer detection rates. This study examined the effect of arbitration of indeterminate (score 3) mammograms only following consensus decision to recall. …
Metadata
Title
''Might be something, might not'' - what happens when indeterminate grade screening mamograms are arbitrated?
Authors
J Prynn
N Barr
C Boggis
E Hurley
M Wilson
Publication date
01-10-2009
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2009
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2372

Other articles of this Special Issue 2/2009

Breast Cancer Research 2/2009 Go to the issue

Poster presentation

Screen-detected ductal carcinoma in situ - fine needle aspiration versus core biopsy

Poster presentation

Performance in digital mammography with and without film prior mammograms

Poster presentation

Screen-detected breast cancer: does presence of minimal signs on previous mammograms predict staging/grading of cancer?

Poster presentation

Does breast magnetic resonance imaging measurement correlate with pathology in assessment of primary breast cancer?

Poster presentation

Preoperative ultrasound assessment of axillary lymph nodes in breast cancer: histopathological correlation in 100 cases

Poster presentation

How important is mammographic image manipulation when examining digital screening cases?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits